发明名称 Application of 5-HT<sub>6 </sub>receptor antagonists for the alleviation of cognitive deficits of down syndrome
摘要 Methods for treating Down syndrome and improving cognitive function of a patient with an intellectual disability are disclosed. 5-hydroxytryptamine sub-receptor six (5-HT6) receptor antagonists are provided for improving the cognition of a Down syndrome patient.
申请公布号 US9029379(B2) 申请公布日期 2015.05.12
申请号 US201313837887 申请日期 2013.03.15
申请人 The University of Utah Research Foundation 发明人 Korenberg Julie Ruth;Wilcox Karen Sue;West Peter Jeffrey;Kesner Raymond Pierre
分类号 A61K31/496;A61K31/506;A61K31/4045;A61K31/4985;A61K31/454;C07D487/04;A61K31/404;A61K31/4745;A61K31/505;A61K31/495;A61K45/06;C07D209/14;C07D239/50;C07D295/096;C07D401/04;C07D401/10 主分类号 A61K31/496
代理机构 Stoel Rives LLP 代理人 Stoel Rives LLP
主权项 1. A method of treating Down syndrome, comprising administering to a subject in need thereof an effective amount of a 5-HT6 receptor antagonist, wherein the 5-HT6 receptor antagonist is an effective amount of a compound selected from: compound 1, compound 2, compound 3, compound 4, compound 5, compound 6, and/or compound 7, having the chemical formula: or pharmaceutically acceptable hydrates, solvates, tautomers, salts and complexes thereof.
地址 Salt Lake City UT US